Email Newsletters

Marlborough

Seven recent leases signed in MetroWest

Despite what it said were high vacancy rates in the area, Greater Boston Commercial Properties (GBCP) recently brokered leases for seven properties in the MetroWest area.

Urgent care group to open 2nd Central Mass. site

AFC Doctors Express, a nationwide urgent care franchise, plans to open its second Central Massachusetts location in Marlborough.

Boston equity firm acquires Adcole Corp. of Marlborough

Adcole Corp., a Marlborough-based maker of measuring devices used in manufacturing processes, announced it has been acquired by Artemis Capital Partners, a Boston-based private equity firm, for an undisclosed amount.

RXi initiates phase 2 study

Marlborough-based RXi Pharmaceuticals, a clinical-stage biotechnology company, has initiated a third phase 2 study of its anti-scarring drug RXI-109.
ADVERTISEMENT

BSX profits plunge despite sales growth

Strong sales from several divisions, as well as international growth of 7 percent, were tarnished by heavy expenses as Boston Scientific Corp. (BSX) reported a 97-percent drop in profits in its second-quarter financial results.

Feds approve another BSX stent system

Marlborough-based Boston Scientific Corp. has received federal approval for its latest stent system designed to treat coronary artery disease.

Nonprofit’s One Mortgage program has lenders looking for value

Lenders are finding themselves walking a tightrope between providing lower-income Americans with quality housing and keeping their...

As Israeli biotechs mature, Mass. comes calling

Home to 11 percent of American drug development and more than a fifth of all U.S. biotech venture capital, Massachusetts has particularly piqued the interests of Israelis with life sciences backgrounds.
ADVERTISEMENT

BSX products launched in Europe

Boston Scientific has launched European sales of products designed to treat peripheral artery and aortic valve diseases.

Marlborough’s ReWalk files for IPO

Just weeks after winning federal approval for its home electronic exoskeleton, ReWalk Robotics of Marlborough has filed for an initial public offering of stock with the U.S. Securities and Exchange Commission (SEC).
ADVERTISEMENT

Latest Stories

More Business News
ADVERTISEMENT

Thought Leadership

More Thought Leadership

Career Opportunities

More Jobs | Submit a Job
More Events | Submit an Event

Get our email newsletter

Stay up-to-date on the companies, people and issues that impact businesses in Central Massachusetts.

Close the CTA